12-15623230-A-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000281172.10(EPS8):āc.2283T>Gā(p.Asp761Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00794 in 1,613,380 control chromosomes in the GnomAD database, including 82 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
ENST00000281172.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPS8 | NM_004447.6 | c.2283T>G | p.Asp761Glu | missense_variant | 20/21 | ENST00000281172.10 | NP_004438.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPS8 | ENST00000281172.10 | c.2283T>G | p.Asp761Glu | missense_variant | 20/21 | 1 | NM_004447.6 | ENSP00000281172 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00746 AC: 1134AN: 152070Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.00721 AC: 1809AN: 251016Hom.: 17 AF XY: 0.00748 AC XY: 1015AN XY: 135680
GnomAD4 exome AF: 0.00799 AC: 11678AN: 1461196Hom.: 77 Cov.: 30 AF XY: 0.00805 AC XY: 5853AN XY: 726920
GnomAD4 genome AF: 0.00746 AC: 1136AN: 152184Hom.: 5 Cov.: 32 AF XY: 0.00732 AC XY: 545AN XY: 74424
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 04, 2018 | This variant is associated with the following publications: (PMID: 26721930) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 15, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2023 | EPS8: BS1, BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 26, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 23, 2017 | p.Asp761Glu in exon 20 of EPS8: This variant is not expected to have clinical si gnificance because it has been identified in 0.98% (652/66712) of European chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ; dbSNP rs7137185). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at